Elizabeth H. Z. Thompson
Currently, Elizabeth H. Z. Thompson occupies the position of Executive Vice President-Research & Development at Horizon Therapeutics Plc.
Dr. Thompson previously held the position of Group Director-Scientific Clinical Development at AbbVie, Inc.
Dr. Thompson received an undergraduate degree from Harvey Mudd College and a doctorate from The Scripps Research Institute.
Transactions
04/18/2022 | 8,098 | Disposition at $115.64 per share. | 936,453 |
01/05/2022 | 7,030 | Derivative/Non-derivative trans. at $101.84 per share. | 715,936 |
01/05/2022 | 13,999 | Derivative/Non-derivative trans. at $0 per share. | 0 |
08/05/2021 | 7,542 | Disposition at $106.34 per share. | 802,017 |
07/01/2021 | 5,988 | Derivative/Non-derivative trans. at $96.59 per share. | 578,381 |
07/01/2021 | 12,077 | Derivative/Non-derivative trans. at $0 per share. | 0 |